UMN Pharma Inc. 4585Short Interest

No institution currently reports a short position of 0.5% or more in UMN Pharma Inc. (4585). The last disclosure was on 2019-10-15 (Credit Suisse Securities (Europe) Limited, 0.46%).

Mothers (Domestic) Pharmaceutical Pharmaceutical -
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
72 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 4 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2017-11-02
Latest disclosure2019-10-15 (Credit Suisse Securities (Europe) Limited, 0.46%)
Reporting institutions5 firms (72 reports)
Peak estimated short interest2.69% (2018-02-05, 2 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

No position of 0.5% or more reported within a year existed in the last 5 years, so no chart is shown. Past disclosures are listed in the tables below.

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2017-12-07 JPM Securities Japan Co Ltd. Position 63,400 shares Ratio 0.49% ▼0.09% −11,400 Below 0.5%
2018-06-07 Nomura International plc Position 62,700 shares Ratio 0.48% ▼0.19% −24,000 Below 0.5%
2019-07-31 UBS AG Position 72,300 shares Ratio 0.47% ▼0.11% −17,500 Below 0.5%
2019-10-15 Credit Suisse Securities (Europe) Limited Position 81,545 shares Ratio 0.46% ▼0.07% −12,500 Below 0.5%
2017-11-02 スパークス・アセット・マネジメント株式会社 Position 0 shares Ratio 0.00% ▼0.60% Closed

Disclosure History 72 in total

Trade date Short seller Position (shares) Ratio Change Note
2019-10-15 Credit Suisse Securities (Europe) Limited Position 81,545 shares Ratio 0.46% ▼0.07% −12,500 Below 0.5%
2019-10-11 Credit Suisse Securities (Europe) Limited Position 94,045 shares Ratio 0.53% ▲0.09% +18,817 —
2019-07-31 UBS AG Position 72,300 shares Ratio 0.47% ▼0.11% −17,500 Below 0.5%
2019-07-26 UBS AG Position 89,800 shares Ratio 0.58% ▼0.08% −11,400 —
2019-07-23 UBS AG Position 101,200 shares Ratio 0.66% ▼0.11% −16,800 —
2019-07-17 UBS AG Position 118,000 shares Ratio 0.77% ▼0.03% −5,500 —
2019-07-11 UBS AG Position 123,500 shares Ratio 0.80% ▲0.01% +1,700 —
2019-07-09 UBS AG Position 121,800 shares Ratio 0.79% ▼0.09% −12,900 —
2019-07-05 UBS AG Position 134,700 shares Ratio 0.88% ▼0.10% −15,800 —
2019-07-03 UBS AG Position 150,500 shares Ratio 0.98% ▼0.04% −6,900 —
2019-07-02 UBS AG Position 157,400 shares Ratio 1.02% ▼0.16% −24,000 —
2019-06-28 UBS AG Position 181,400 shares Ratio 1.18% ▼0.09% −14,300 —
2019-06-26 UBS AG Position 195,700 shares Ratio 1.27% ▼0.10% −14,600 —
2019-06-20 UBS AG Position 210,300 shares Ratio 1.37% ▼0.11% −16,400 —
2019-06-17 UBS AG Position 226,700 shares Ratio 1.48% ▼0.11% −17,800 —
2019-06-11 UBS AG Position 244,500 shares Ratio 1.59% ▼0.10% −14,700 —
2019-06-05 UBS AG Position 259,200 shares Ratio 1.69% ▼0.02% −3,000 —
2019-05-23 UBS AG Position 262,200 shares Ratio 1.71% ▲0.40% +61,300 —
2019-05-15 UBS AG Position 200,900 shares Ratio 1.31% ▲0.09% +13,500 —
2019-04-25 UBS AG Position 187,400 shares Ratio 1.22% ▲0.03% +5,300 —
2019-04-24 UBS AG Position 182,100 shares Ratio 1.19% ▼0.01% −2,000 —
2019-04-23 UBS AG Position 184,100 shares Ratio 1.20% ▲0.07% +11,200 —
2019-04-18 UBS AG Position 172,900 shares Ratio 1.13% ▲0.05% +7,400 —
2019-04-17 UBS AG Position 165,500 shares Ratio 1.08% ▲0.15% +22,000 —
2019-04-16 UBS AG Position 143,500 shares Ratio 0.93% ▲0.24% +37,900 —
2019-04-12 UBS AG Position 105,600 shares Ratio 0.69% ▲0.37% —
2018-12-11 Credit Suisse Securities (Europe) Limited Position 75,228 shares Ratio 0.49% ▼0.10% −16,300 Below 0.5%
2018-11-26 Credit Suisse Securities (Europe) Limited Position 91,528 shares Ratio 0.59% ▼0.03% −3,500 —
2018-11-21 Credit Suisse Securities (Europe) Limited Position 95,028 shares Ratio 0.62% ▼0.17% −7,100 —
2018-10-02 Credit Suisse Securities (Europe) Limited Position 102,128 shares Ratio 0.79% ▼0.09% −11,400 —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector